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Brugada syndromeSudden infant death syndrome (SIDS) is characterized by the sudden death of an infant that occurs during
sleep and remains unexplained despite thorough examination. In addition to clinical associations such as
prone sleeping and exposure to cigarette smoke, several genetic factors have been identiﬁed with regard to
SIDS, including autonomic disorders, immunologic polymorphisms and metabolic disorders. In the past
decade, postmortem genetic analysis (‘molecular autopsy’) of SIDS cases has revealed a number of cardiac ion
channel mutations that are associated with arrhythmia syndromes, including the long QT syndrome, Brugada
syndrome and short QT syndrome. Mutations have been found in genes encoding (subunits of) cardiac
potassium, sodium and calcium channels, as well as in genes involved in the trafﬁcking or regulation of these
channels. Here, we review the literature on cardiac ion channel mutations in relation to SIDS. Combining data
from population-based cohort studies, we conclude that at least one out of ﬁve SIDS victims carries a mutation
in a cardiac ion channel-related gene and that the majority of these mutations are of a known malignant
phenotype. Genetic analysis is therefore recommended in cases of sudden infant death. More research is
required to further elucidate the pathophysiology of SIDS and to determine whether genetic or
electrocardiographic screening of apparently healthy infants should be pursued.Embryology and Physiology,
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The term ‘sudden infant death syndrome’ (SIDS) was ﬁrst
proposed in 1969, to describe “the sudden death of any infant or
young child which is unexpected by history, and in which a thorough
postmortem examination fails to demonstrate an adequate cause of
death” [1]. Several reconsiderations led to further speciﬁcation of this
deﬁnition, limiting the victim's age to b1 year, specifying that death
apparently occurred during sleep and stating that thorough exami-
nation should include complete autopsy and review of the death
scene and clinical history [2]. Also, it has been proposed to classify
SIDS cases into different categories according to their features and
documentation [2]. Despite these attempts, the deﬁnitions and
protocols used for diagnosing SIDS have never been fully standard-
ized, and SIDS still remains a diagnosis of exclusion [3].
The prevalence of SIDS has decreased considerably since the 1992
American Academy of Pediatrics recommendation to avoid for babies
to sleep in the prone position, and the subsequent international ‘Back
to Sleep’ campaign [4]. Nevertheless, SIDS has until today remained a
major cause of infant mortality in developed countries. Accounting forover 2100 deaths, it was the third most important cause of infant
mortality in the United States in 2007 [5].
Despite its relatively high prevalence, the exact pathophysiology of
SIDS is still poorly understood. Many mechanisms have been
suggested and investigated, including infections and several genetic
abnormalities. Presumably, SIDS is a multifactorial disorder, with
multiple mechanisms resulting in or predisposing to its development.
This reinforces the relevance of the search for preventable causes. In
line with the presumed multifactorial nature of SIDS, several ‘triple
risk’ hypotheses—with three risk factors contributing to SIDS, e.g. a
vulnerable infant, a critical developmental period in homeostatic
control, and an exogenous stressor—have been proposed, but none of
these have signiﬁcantly improved our understanding of the cause of
SIDS [6].
In this paper, our main aim is to review the literature in which
cardiac ion channel mutations are described as a possible cause or
predisposing factor of SIDS. Additionally, we will ﬁrst give a brief
overview of several clinical associations and non-cardiac genetic
factors that have been reported with regard to SIDS.
2. Clinical associations
Risk factors for SIDS include male gender, age two to four months,
prematurity, low birth weight, poor prenatal medical care, low
socioeconomic status of the family, young age of parents, parental
low educational level, short periods between pregnancies, multiple
pregnancy, drug intake by pregnant woman, winter months, prone
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birth, and overheating [3]. Most deaths occur during the night and
earlymorning [7]. Additionally, epidemiological studies have reported
ethnic differences in the incidence of SIDS; it is signiﬁcantly higher
among indigenous groups than among non-indigenous groups from
the same countries [8]. These variations were found to be associated
with both genetic and environmental factors.
Already in the 1960s, infections were proposed to contribute to the
etiology of sudden unexpected infant death [9], and substantial
evidence has since then become available to support this hypothesis.
Inﬂammatory changes are commonly found in SIDS cases, and mild
viral infection is an established risk factor for SIDS [7,10]. Several
studies have shown that the incidence of SIDS varies in correlation to
the incidence of infectious diseases, both on seasonal and yearly bases
[10,11]. Among the pathogens that have been speciﬁcally reported in
association with SIDS are Staphylococcus aureus, streptococci and
Escherichia coli [7].
Additionally, some established risk factors for SIDS are reported to
parallel risk factors for susceptibility of infants to infection. These
include ethnicity, male gender, prone sleeping, cigarette smoke ex-
posure, overheating, mild respiratory infections, lack of breastfeeding
and poor socioeconomic conditions [7].
3. Non-cardiac genetic factors
3.1. Immunologic polymorphisms
The current most popular hypothesis on the mechanism by which
infections provoke SIDS, is that pathogenic toxins give rise to an
overwhelming pro-inﬂammatory cytokine response, ultimately caus-
ing physiological changes that lead to death [7]. This hypothesis is
supported by the observation that several immunologic polymor-
phisms which facilitate uncontrolled inﬂammatory responses are
found at a higher proportion in SIDS victims than in controls. Among
the altered inﬂammatory responses that have been suggested to be
associated with SIDS, are underproduction of the anti-inﬂammatory
cytokine interleukin-10 (IL-10), overexpression of the powerful
cytokines IL-1β and IL-6, and elevated vascular endothelial growth
factor (VEGF) [7,10]. Altered cytokine responses have also been
hypothesized to be the mechanism by which exposure to cigarette
smoke predisposes to SIDS [7].
3.2. Autonomic disorders
Several structural and neurotransmitter alterations in the brain-
stem, consistent with impaired autonomic regulation, have been
found in cases of SIDS [12]. These alterations include serotonergic
abnormalities in the medulla oblongata [12–14]. Serotonin is a
widespread neurotransmitter involved in many functions of the
central nervous system, including respiratory and cardiovascular
regulation. It has been hypothesized that the mechanism by which
serotonergic dysfunction leads to SIDS, is through failure of protective
respiratory and autonomic responses to life-threatening hypoxia or
hypercapnia during sleep [12,13].
Genetic analyses have identiﬁed polymorphisms in the variable
tandem repeat sequence in the promoter region of the serotonin
transporter (5-HTT) gene. SIDS victims are more likely than matched
controls to have the long allele of this gene [15,16]. Increasing
effectiveness of the promoter and therefore of serotonin re-uptake by
the serotonin transporter, this allele facilitates decreased serotonin
concentrations at nerve endings.
Further genetic factors have been identiﬁed. Weese-Mayer et al.
[17] analyzed several genes pertinent to early embryologic develop-
ment of the autonomic nervous system. They identiﬁed rare protein-
changing polymorphisms in association with SIDS in ﬁve genes
(PHOX2a, RET, ECE1, TLX3 and EN1). After investigating left ventricularand blood samples from nine SIDS cases, Livolsi et al. [18] reported
cholinergic abnormalities in the intracardiac part of the autonomic
nervous system. Compared with controls, SIDS cases showed an
increase in both the density of cardiac muscarinic receptors and the
erythrocyte acetylcholinesterase enzyme activity.
3.3. Metabolic disorders
In 1976, Sinclair-Smith et al. [19] were the ﬁrst to investigate the
ribs, livers and thymi of children who died of SIDS. In over 90% of 200
SIDS cases, the costochondral junction indicated that death was
preceded by retardation in growth velocity. Additionally, 90% of livers
showed fatty change indicating a metabolic upset, which in 5% was of
severe degree. Postmortem biochemical screening of 313 livers from
SIDS cases by Boles et al. [20], implicated abnormalities in several
distinct fatty acid oxidation pathways in 14 infants (4.4%).
A well-investigated metabolic disorder studied in relation to SIDS
is medium-chain acyl-CoA dehydrogenase (MCAD) deﬁciency. This
relatively common autosomal recessive inherited disease results from
a deﬁciency in the enzyme which catalyzes the ﬁrst step in β-
oxidation of fatty acids. At least nine studies investigated SIDS
populations with regard to p.A985G, the most prevalent mutation
causing MCAD deﬁciency [21]. Overall, p.A985G heterozygosity was
found in only 0.54% of 2587 SIDS cases, compared with 0.84% of 4636
control cases.
The fact that low birth weight, which is a risk factor for SIDS, is
associated with hypoglycemia, has triggered investigation of gene
polymorphisms in two key enzymes in blood glucose homeostasis:
glucokinase (GK) and hepatic glucose-6-phosphatase (G6PC1).
Whereas low G6PC1 expression and activity were found in some
SIDS victims [22–24], no signiﬁcant alterations have yet been
identiﬁed regarding GK [23].
4. Cardiac genetic factors
Already in 1976, the long QT syndrome (LQTS) was proposed as a
possible cause of SIDS [25,26]. LQTS is characterized by delayed
cardiac repolarization, resulting in QT prolongation on the electro-
cardiogram (ECG) and a predisposition to syncope, seizures and
sudden cardiac death [27,28]. These clinical features are caused by
episodic polymorphic ventricular tachyarrhythmias such as Torsades
de Pointes (TdP). Especially in young people, LQTS is an important
cause of unexpected death. All features of LQTS, including a negative
postmortem examination, are compatible with SIDS. In many cases,
LQTS is an inherited disorder, caused by mutations in genes
predominantly encoding subunits of cardiac ion channels [27,28].
At the cellular level, LQTS is characterized by an increase in action
potential duration, as illustrated in Fig. 1A, which may result from an
increase in inward current during the plateau phase of the action
potential (AP), e.g. due to an increase in the late component of the fast
sodium current (INa; ‘gain of function’), or a decrease in outward
current, e.g. due to a decrease in the rapid or slow delayed rectiﬁer
potassium current (IKr and IKs, respectively; ‘loss of function’).
Mutations in cardiac ion channel genes may also lead to the
Brugada syndrome (BrS) and the short QT syndrome (SQTS) [29,30],
which share several clinical features with LQTS, such as a predispo-
sition to sudden cardiac death. The Brugada syndrome is character-
ized by changes in the ST segment of the ECG rather than QT
prolongation, which may result from transmural dispersion in AP
duration, in particular in the right ventricle, due to an early
repolarization in the epicardial cell layers. On a cellular basis, a
decrease in the peak component of INa due to a loss-of-function
mutation in SCN5A, i.e. the gene encoding the pore-forming α subunit
of the INa channel, may lead to loss of the AP dome in cells with a large
transient outward current, like the right ventricular epicardial
cells (Fig. 1B). It should be noted that this explanation of BrS as a
Fig. 1. Diagram of the left ventricular (LV) or right ventricular (RV) endocardial (endo) or epicardial (epi) action potential in case of (A) long QT syndrome, (B) Brugada syndrome,
and (C) short QT syndrome. The dashed blue lines indicate control action potentials. Arrows mark the change in action potential conﬁguration associated with the syndrome.
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the same time, be a depolarization disease [31]. In contrast with LQTS,
the short QT syndrome is characterized by a shortening of the QT
interval on the ECG and, at the cellular level, a shortening of the action
potential (Fig. 1C). The shorter AP may result from gain-of-function
mutations in genes related to outward currents that ﬂow during the
repolarization phase of the action potential, e.g. IKr and IKs. SQTS types
1 and 2 (SQT1 and SQT2) are caused by gain-of-function mutations in
KCNH2 (also known as HERG) and KCNQ1 (also known as KVLQT1),
which encode the α subunit of the IKr and IKs channel, respectively.
Since the proposal of LQTS as a possible cause of SIDS in 1976
[25,26], genetic or clinical correlations between LQTS and SIDS have
been found in several studies. In 1998, Schwartz et al. [32] reported
results from a 19-year electrocardiographic assessment of Italian
neonates at day three or four of life. Of the 34,442 infants enrolled,
one-year follow-up data were available for 33,034. In this cohort, 24
infants died of SIDS. Their mean rate-corrected QT interval (QTc) was
signiﬁcantly longer than that of infants who survived or died of other
causes. More importantly, in 12 of them QTc was considered to be
prolonged (N440 ms), whereas it was not in any of the 10 infants who
died of other causes. It was found that the presence of QTc pro-
longation in the ﬁrst week of life increased the risk of SIDS by 41
times. In 2000 and 2001, a number of case reports were published on
mutations in LQTS genes in SIDS or near-SIDS [33–35], starting with
the description by Schwartz et al. [33] of an infant who nearly died of
SIDS and in whom LQTS was diagnosed and a spontaneous mutation
in SCN5A was identiﬁed, providing a ‘proof of concept’ of cardiac ion
channelopathies as a cause of SIDS. Shortly thereafter, Ackerman et al.
[36] reported the results of the ﬁrst population-basedmolecular study
screening for mutations in LQTS genes as the possible cause of SIDS.
The ﬁndings by Schwartz et al. [32] initiated an ongoing discussion
about the feasibility and relevance of neonatal electrocardiographic
screening [37,38], identifying infants with LQTS and thus at risk for
SIDS. In Italy, a large prospective ECG study in a population of 44,596
neonates was recently completed [39]. In 28 of the 29 infants
with marked QT interval prolongation (QTc N470 ms), a molecular
screening for mutations in any of the LQTS genes KCNQ1, KCNH2,
SCN5A, KCNE1, KCNE2, CAV3 and SCN4B, associated with the LQTStypes 1–3, 5, 6, 9 and 10, respectively, was performed. This revealed
LQTS mutations in 12 neonates. Another three mutations were
identiﬁed upon genetic analysis of 14 of the 28 neonates with a QTc
between 461 and 470 ms. All but one, because of parental refusal, of
the 29 neonates with a QTc N470 ms were successfully treated with a
β-blocker (propranolol). It is tempting to speculate that this treat-
ment has prevented the occurrence of SIDS in this group.
Postmortem genetic analysis of SIDS cases, screening formutations
in LQTS genes and related genes, has revealed associations of muta-
tions in these genes with SIDS, as summarized in Table 1. This table is
based on ﬁndings from population-based cohort studies and case
reports. These ﬁndings are detailed in Sections 4.1–4.4 and summa-
rized in Tables 2 and 3.
4.1. Cardiac potassium channel mutations
In 2005, more than 400 different LQTS-associated mutations had
already been identiﬁed, the majority of which were localized in the IKs
and IKr channel genes KCNQ1 and KCNH2, underlying the LQTS types 1
and 2 (LQT1 and LQT2, respectively) [27,30]. Less frequently, defects
are found in two other potassium channel genes, KCNE1 (LQT5) and
KCNE2 (LQT6), which encode auxiliary β subunits of the IKs and IKr
channel, respectively. These defects in potassium channel genes cause
LQTS by reducing the repolarizing current carried by the speciﬁc
potassium channel they encode, i.e. the IKs (KCNQ1 and KCNE1) and
the IKr channel (KCNH2 and KCNE2). A number of LQTS-associated
mutations in these potassium channel genes have been identiﬁed in
SIDS cases. In addition, SIDS-related mutations in KCNJ8, encoding the
pore-forming α subunit of the ATP-sensitive potassium channel, have
recently been reported.
In their population-based collection of 93 unexplained infant
deaths [36], Tester and Ackerman [40] screened for mutations in
KCNQ1, KCNH2, KCNE1 and KCNE2, and found novel potassium
channel variants in KCNQ1 (p.T600M), KCNH2 (p.G294V) and KCNE2
(p.V14I), as listed in Table 2. In addition, they also discovered a novel
mutation in KCNH2 (p.P1157L) following postmortem genetic testing
in a separate case of an infant who was found dead in the prone sleep
position (Table 3). None of these mutations was seen in nearly 1500
Table 1
Cardiac ion channel-related genes associated with SIDS.
Gene Protein Functional role in cardiomyocytes Effect of mutation Clinical syndrome
Potassium channel genes
KCNQ1 (KVLQT1) Kv7.1 (KvLQT1) α subunit of IKs channel IKs loss of function
IKs gain of function
LQT1
SQT2
KCNE1 minK β subunit of IKs channel IKs loss of function LQT5
KCNH2 (HERG) Kv11.1 α subunit of IKr channel IKr loss of function LQT2
KCNE2 MiRP1 β subunit of IKr channel IKr loss of function LQT6
KCNJ8 Kir6.1 α subunit of IK,ATP channel IK,ATP loss of function –
Sodium channel genes
SCN5A Nav1.5 α subunit of INa channel INa loss of function
INa gain of function
BrS1
LQT3
SCN3B Navβ3 β subunit of INa channel INa loss of function BrS7
SCN4B Navβ4 β subunit of INa channel INa gain of function LQT10
Calcium channel genes
RYR2 RyR2 Ryanodine receptor in SR membrane Calcium leak from SR CPVT1
Other genes
CAV3 Caveolin-3 Caveolar coating INa gain of function LQT9
GPD1-L G3PD1L Not fully established INa loss of function BrS2
SNTA1 α1-syntrophin Scaffolding protein INa gain of function LQT12
GJA1 Cx43 Gap junction protein Ij loss of function –
IKs: slow delayed rectiﬁer potassium current; IKr: rapid delayed rectiﬁer potassium current; IK,ATP: ATP-sensitive potassium current; INa: fast sodium current; Ij: gap junctional
current; LQT1–12: long QT syndrome types 1–12; SQT2: short QT syndrome type 2; BrS1–7, Brugada syndrome types 1–7; CPVT1: cathecholaminergic polymorphic ventricular
tachycardia type 1.
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functional evidence, e.g. from in vitro expression studies, that any of
these four mutations leads to potassium channel dysfunction and
these are therefore not classiﬁed as ‘functionally signiﬁcant’ in
Tables 2 and 3. Furthermore, the KCNQ1-p.T600M and KCNH2-p.G294V
variants occurred in the same black victim, together with the sodium
channel variant SCN5A-p.S1103Y, which has later been associated with
sudden infant death in African Americans [41] (see Section 4.2).
Wedekind et al. [42] performed a postmortem examination in a
total of 41 SIDS cases of sudden and unexpected infant death, which
occurred in 1991/1992 and 1995/1996 in the northwestern area of
Germany. Apart from a number of common and rare polymorphisms,
the results of screening for mutations in the LQTS genes KCNQ1,
KCNH2, SCN5A, KCNE1 and KCNE2, associated with the LQTS types 1–3,
5 and 6, respectively, were limited to a single missense mutation in
KCNQ1 (p.H105L). However, the mutant channel failed to display
signiﬁcant electrophysiological disturbances in vitro.
Between 1988 and 2004, Arnestad et al. [43] genetically analyzed
201 Norwegian cases of SIDS, screening for mutations in KCNQ1,
KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2 and CAV3, associated with LQTS
types 1–3, 5–7 and 9, respectively. Mutations and rare variants in
LQTS genes were identiﬁed in 26 cases. On the basis of the available
functional data, 8 mutations and 7 rare variants found in 19 of 201
cases (9.5%) were considered as likely contributors to sudden death.
In 11 cases, nine different mutations or rare variants in the potassium
channel genes KCNQ1 (5 cases), KCNH2 (5 cases), and KCNE2(one
case) were found (Table 2). No mutations were found in KCNE1 or
KCNJ2. However, one rare KCNQ1 variant (p.P448R, three cases)
appeared a common, ethnic-speciﬁc polymorphism [44], whereas the
mutations p.V279M, p.R885C and p.S1040G in KCNH2 (three cases in
total) exhibited biophysical properties indistinguishable from wild-
type [45] and are probably benign variants. For the remaining ﬁve
cases clear functional effects have been found [43,45]. The functional
characterization of the KCNH2-p.R273Q, KCNH2-p.R954C/p.K897T and
KCNE2-p.Q9E mutations reveals a loss of function of the associated
current (IKr), which would result in a long-QT phenotype. The func-
tional effect of the KCNQ1mutations is a loss of function (p.G460S) or
gain of function (p.I274V) of the associated current (IKs), which would
result in a long-QT or short-QT phenotype, respectively.
In 2008, Otagiri et al. [46] reported the results of an investigation of
42 Japanese SIDS cases between 1995 and 2004. They studied the LQTS
genesKCNQ1,KCNH2 and SCN5A and identiﬁed twopotassium channelmutations, one in KCNQ1 (p.K598R) and one in KCNH2 (p.T895M). The
KCNQ1-p.K598Rmutation did not noticeably alter the gating of KCNQ1
channels expressed in oocytes and was therefore considered a rare
polymorphism. However, thismutation has recently been identiﬁed as
an LQT1 causing mutation in a clinical study [47]. Biophysical
properties of KCNH2-p.T895M included a decrease in amplitude of
the steady-state current and a delay in deactivation. Since these
alterations seem to exert opposite functional effects, it is difﬁcult to
predict the overall in vivo effect of this mutation, especially as the
subject it was found in also carried a defect in SCN5A (see Section 4.2).
Millat et al. [48] performed genetic screening of 32 French SIDS
victims of Caucasian origin for mutations in KCNQ1, KCNH2, SCN5A,
KCNE1 and KCNE2, and found three potassium channel mutations, one
in each of the genes KCNQ1, KCNH2 and KCNE1 (KCNQ1-p.G626S,
KCNH2-p.R148W and KCNE1-p.T20I) and none in KCNE2. These
mutations were interpreted by the authors as a possible cause of
death. With regard to the KCNQ1mutation, some evidence is available
to support this hypothesis [49]. However, the infant with the KCNE1
mutation was also carrier of a spontaneous mutation in SCN5A that
may provide a more likely explanation for her death, given that her
father was found to be carrier of the KCNE1-p.T20I mutation with no
LQTS-related phenotype [50]. The KCNH2 defect is probably a benign
polymorphism [51], as supported by the observation that the father,
who also carried the mutation, was asymptomatic.
Recently, Tester et al. [52] performed a mutational analysis of
KCNJ8 on genomic DNA obtained from 292 unrelated SIDS victims.
Two distinct and novel KCNJ8 mutations were identiﬁed (p.E332del
and p.V346I). Both cases were negative for mutations in established
channelopathic genes. In vitro, bothmutations resulted in a signiﬁcant
decrease in the associated ATP-sensitive potassium current (IK,ATP).
Loss of function of the KCNJ8-encoded cardiac KATP channel may result
in a long-QT phenotype, predisposing to SIDS, but an isolated pro-
arrhythmic mechanism remains speculative since KCNJ8 is expressed
in multiple tissues, including vascular and neuronal tissue [52].
In addition to the previously discussed cohort studies, a number of
case reports are available in literature (Table 3). In 2001, Schwartz
et al. [34] reported the identiﬁcation of a de novo KCNQ1 mutation
(p.P117L), which was associated with clinical LQTS in an unrelated
family, in an infant who died of SIDS. Additionally, a Scandinavian
group found a novel mutation in KCNH2 (p.K101E) in a seven-week-
old SIDS victim [53]. Because of a positive family history for clinical
LQTS and documented TdP, it was assumed that this mutation
Table 2
Cardiac ion channel-related mutations in population-based cohort studies of SIDS.
Gene Study Number of cases Reported mutations*
Total With mutation Functionally signiﬁcant
Potassium channel genes
KCNQ1 Tester and Ackerman [40] 93 1 0 p.T600M
Wedekind et al. [42] 41 1 0 p.H105L
Arnestad et al. [43] 201 5 2 p.I274V, p.P448R (3 cases), p.G460S
Otagiri et al. [46] 42 1 1 p.K598R
Millat et al. [48] 32 1 1 p.G626S
Total 409 9 (2.2%) 4 (1.0%)
KCNE1 Tester and Ackerman [40] 93 0 0 –
Wedekind et al. [42] 41 0 0 –
Arnestad et al. [43] 201 0 0 –
Millat et al. [48] 32 1 0 p.T20I
Total 367 1 (0.3%) 0
KCNH2 Tester and Ackerman [40] 93 1 0 p.G294V
Wedekind et al. [42] 41 0 0 –
Arnestad et al. [43] 201 5 2 p.R273Q, p.V279M, p.R885C, p.R954C/p.K897T, p.S1040G
Otagiri et al. [46] 42 1 0 p.T895M
Millat et al. [48] 32 1 0 p.R148W
Total 409 8 (2.0%) 2 (0.5%)
KCNE2 Tester and Ackerman [40] 93 1 0 p.V14I
Wedekind et al. [42] 41 0 0 –
Arnestad et al. [43] 201 1 1 p.Q9E
Millat et al. [48] 32 0 0 –
Total 367 2 (0.5%) 1 (0.3%)
KCNJ2 Arnestad et al. [43] 201 0 0 –
KCNJ8 Tester et al. [52] 292 2 (0.7%) 2 (0.7%) p.E332del, p.V346I
Sodium channel genes
SCN5A Ackerman et al. [36] 93 2 2 p.A997S, p.R1826H
Wedekind et al. [42] 41 0 0 –
Plant et al. [41] 133 7 7 Homozygous p.S1103Y (3 cases), p.S524Y (2 cases),
p.R689H, p.E1107K
Arnestad et al. [43] 201 13 13 p.S216L, p.A586_L587del, p.R680H, p.R1193Q (2 cases),
p.T1304M, p.F1486L, p.V1951L, p.F2004L (3 cases),
p.P2006A (2 cases)
Otagiri et al. [46] 42 3 3 p.F532C, p.G1084S, p.F1705S
Millat et al. [48] 32 3 1 p.Q692K, p.R975W, p.S1333Y
Total 542 28 (5.2%) 26 (4.8%)
SCN1B Tan et al. [63] 292 0 0 –
SCN2B Tan et al. [63] 292 0 0 –
SCN3B Tan et al. [63] 292 2 (0.7%) 2 (0.7%) p.V36M, p.V54G
SCN4B Tan et al. [63] 292 1 (0.3%) 1 (0.3%) p.S206L
Calcium channel genes
RYR2 Tester et al. [73] 134 2 (1.5%) 2 (1.5%) p.R2267H, p.S4565R
Other genes
CAV3 Cronk et al. [77] 134 3 3 p.V14L, p.T78M, p.L79R
Arnestad et al. [43] 201 3 2 p.C72W, p.T78M (2 cases)
Total 335 6 (1.8%) 5 (1.5%)
GPD1L Van Norstrand et al. [79] 221 2 (0.9%) 2 (0.9%) p.I124V, p.R273C
SNTA1 Cheng et al. [84] 292 8 (2.7%) 3 (1.0%) p.G54R, p.P56S (3 cases), p.T262P, p.S287R, p.T372M, p.G460S
GJA1 Van Norstrand et al. [85] 292 2 (0.7%) 1 (0.3%) p.E42K, p.S272P
*Functionally signiﬁcant mutations listed in bold.
Table 3
Cardiac ion channel-related mutations in case reports of SIDS or near-SIDS.
Gene Study Findings Reported mutation*
Potassium channel genes
KCNQ1 Schwartz et al. [34] De novo missense mutation identiﬁed in a case of SIDS p.P117L
KCNH2 Christiansen et al. [53] Novel missense mutation identiﬁed in a case of SIDS p.K101E
Tester and Ackerman [40] Novel missense mutation identiﬁed in a case of SIDS p.P1157L
Nof et al. [54] Common polymorphism (p.K897T) and nonsense mutation (p.P926AfsX14) on separate alleles identiﬁed in a
case of sudden infant death and a case of spontaneous abortion within a single family
p.P926AfsX14/p.K897T
Sodium channel genes
SCN5A Schwartz et al. [33] De novo missense mutation identiﬁed in a near-SIDS case with documented QTc prolongation, Torsades de
Pointes and ventricular ﬁbrillation
p.S941N
Wedekind et al. [35] De novo missense mutation identiﬁed in a case of sudden infant death with documented QTc prolongation
and polymorphic ventricular tachyarrhythmias
p.A1330P
Skinner et al. [65] Missense mutation identiﬁed in a near-SIDS case with documented marginal QTc prolongation and ventricular
ﬁbrillation
p.R1193Q
Turillazzi et al. [67] Nonsense mutation identiﬁed in a case of simultaneous sudden infant death syndrome p.W822X
Huang et al. [50] De novo missense mutation identiﬁed in a case of SIDS p.S1333Y
*Functionally signiﬁcant mutations listed in bold.
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presented a family in which an inherited common polymorphism
in KCNH2 (p.K897T) combined with a loss-of-function mutation
(p.P926AfsX14) on separate alleles of the same gene led to sudden
infant death and spontaneous abortion. Family members with only
the polymorphism or only the mutation did not have any events of
syncope or sudden cardiac death. Co-expression studies demon-
strated a much greater loss of function of KCNH2 current in case of
p.P926AfsX14/p.K897T than for p.P926AfsX14 or p.K897T alone.
4.2. Cardiac sodium channel mutations
Gain-of-function mutations in the cardiac sodium channel gene
SCN5A can cause LQTS, due to a persistent inward sodium current
during myocardial repolarization [27]. Although defects in SCN5A
account for only≈10% of LQTS cases [55,56], this subtype (LQT3) does
seem to play a rather important role in the etiology of SIDS. In general,
it appears that patients with LQT3 have signiﬁcantly more severe
clinical events than patients with LQT1 or LQT2, as the overall number
of cardiac deaths is similar for these subgroups while the frequency of
events is lower in LQT3 [57]. Since the initial case report by Schwartz
et al. [33], several SCN5A mutations have been identiﬁed in cohort
studies of SIDS cases. In addition, a number of further case reports of
an SCN5A mutation in a SIDS victim have been published.
Ackerman et al. [36] genetically analyzed postmortem cardiac
tissue from 45 SIDS and 48 possible SIDS cases, obtained between
September 1997 and August 1999 in the State of Arkansas, USA, for
mutations in SCN5A. The same cohort was used in subsequent studies
on ion channelopathies in relation to SIDS, e.g. the aforementioned
study by Tester and Ackerman [40]. In two of these 93 cases, a
missense mutation in SCN5A was found (p.A997S and p.R1826H). In
either case, mutant channels expressed a sodium current character-
ized by slower decay and a two- to threefold increase in late sodium
current, which would result in an LQT3 phenotype. As mentioned in
Section 4.1, Wedekind et al. [42] also screened for mutations in SCN5A
in their 41 German SIDS cases. However, they did not ﬁnd mutations
in this gene.
Plant et al. [41] studied the prevalence of SCN5A variants among
133 African American SIDS cases, and found homozygous and rare
heterozygous SCN5A variants in seven cases (5%). Three cases were
homozygous for p.S1103Y, a variant that had previously been asso-
ciatedwith increased risk for arrhythmia in adults [58]. Comparison to
controls gave an approximately 24-fold increase in risk of SIDS with
the homozygous p.S1103Y genotype. In vitro, the variant p.Y1103
channels operated normally under baseline conditions, but showed
abnormal function when subjected to lowered intracellular pH, which
may indicate a predisposition to acidosis-induced arrhythmia. Three
mutations in SCN5A at sites other than 1103 were identiﬁed in a total
of four cases—p.S524Y (two cases), p.R689H, and p.E1107K—and
characterized as gain-of-function mutations.
In the aforementioned study of 201 Norwegian SIDS cases by
Arnestad et al. [43], nine SCN5A mutations or rare genetic variants
were found in a total of 13 cases (6.5%). Biophysical characterization
of the p.R1193Q variant [59] and the eight other mutations or rare
variants [60] revealed an increased persistent sodium current in all
cases, either under control conditions or only under conditions of
internal acidosis (p.R680H) or when expressed in the context of the
common splice variant p.Q1077del (p.A586_L587del and p.V1951L).
Mutations in SCN5Awere also found in the aforementioned studies
by Otagiri et al. [46] andMillat et al. [48]. In their 42 SIDS cases, Otagiri
et al. [46] observed three mutations in SCN5A (p.F532C, p.G1084S and
p.F1705S). In expression studies, the latter two showed hyperpolariz-
ing shifts in inactivation (p.G1084S and p.F1705S) and a delayed
recovery from inactivation (p.F1705S), loss-of-function features
commonly seen in Brugada syndrome mutations in SCN5A. As for
SCN5A-p.F532C, Otagiri et al. [46] found no evidence indicating afunctionally perturbed channel in their expression experiments, but
this mutation has recently been associated with the Brugada
syndrome [61]. In their 32 SIDS victims, Millat et al. [48] also found
three SCN5Amutations (p.Q692K, p.R975W and p.S1333Y). However,
the ﬁrst has wild-type like functional properties [62] and has recently
been classiﬁed as a control variant [61], whereas the second is
currently considered a rare control [51,61]. SCN5A-p.S1333Y causes a
defect in inactivation with the presence of a residual current, com-
parable to LQT3 [50].
Tan et al. [63] screened their cohort of 292 SIDS cases formutations
in the four sodium channel β subunit genes SCN1B to SCN4B, and
identiﬁed a total of three mutations in two of these genes (SCN3B-
p.V36M, SCN3B-p.V54G and SCN4B-p.S206L). The two SCN3B
mutations are both localized in the extracellular loop of the β
subunit, which is important for β3 membrane trafﬁcking. Com-
pared with wild-type channels, p.V36M channels showed both
loss-of-function and gain-of-function phenotypes in expression
studies, i.e. decreased peak INa and increased late INa (at least when
normalized to peak INa), respectively, whereas p.V54G was purely
loss-of-function. SCN4B-p.S206L is associated with an increase in
late sodium current, as demonstrated through adenoviral trans-
duction of adult rat ventricular myocytes [63].
In addition to the previously mentioned cohort studies, a number
of case reports on SCN5A mutations in SIDS or near-SIDS have been
published (Table 3). In 2000, Schwartz et al. [33] reported a case of a
44-day-old boy with a normal clinical and family history, who had
suddenly gone into ventricular ﬁbrillation. After successful deﬁbril-
lation the infant was diagnosed with LQTS, and subsequent genetic
testing demonstrated a de novo missense mutation in SCN5A
(p.S941N) with an increase in late sodium current. The p.A1330P
protein change is another SCN5A defect described in a case report of
sudden infant death [35]. Functional analysis of this mutation
showed a positive shift in voltage dependence of inactivation, a
slowing of the time course of inactivation, and faster recovery from
inactivation [35]. A direct demonstration of the mutation effects on
the action potential was obtained in ‘dynamic action potential
clamp’ experiments by Berecki et al. [64]. In 2005, Skinner et al.
[65] reported a near-SIDS case of a 19-day-old infant. Genetic
analysis revealed a missense mutation in SCN5A (p.R1193Q) that
had been associated with the Brugada syndrome in a previous
study [66]. This mutation was also found in the SIDS cohort of
Arnestad et al. [43] and characterized as an LQT3 mutation by Wang
et al. [59]. In another case report [67], the heterozygous p.W822X
nonsense mutation in SCN5A was linked to the death of both
members of a set of monozygotic healthy twins (‘simultaneous
sudden infant death syndrome’, SSIDS). This mutation had been
linked to the Brugada syndrome in a previous study [68]. Finally,
there is a case report on a de novo p.S1333Y mutation in SCN5A
identiﬁed in a SIDS victim who also carried the p.T20I mutation in
KCNE1 [50]. This SIDS victim appears as case 46 in the study by
Millat et al. [48]. In addition to these case reports, Priori et al. [69]
reported on two cases of SIDS in a family with Brugada syndrome
and the p.L567Q mutation in SCN5A, which was later functionally
characterized as a loss-of-function mutation by Wan et al. [70].
Although direct genetic data of the two victims are not available, it
is likely that they carried the familial p.L567Q mutation.
4.3. Cardiac calcium channel mutations
Cathecholaminergic polymorphic ventricular tachycardia (CPVT)
is an inherited arrhythmogenic disorder, characterized by adrenergi-
cally mediated polymorphic ventricular tachyarrhythmias in the
absence of electrocardiographic markers and structural heart disease
[71]. CPVT1 is the autosomal dominant form of the disease, caused by
mutations in the RYR2-encoded cardiac ryanodine receptor that is
located in the membrane of the sarcoplasmic reticulum (SR). This
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release, which is triggered by the small rise in intracellular calcium
through activation of voltage sensitive L-type calcium channels upon
membrane depolarization.
A 2004 study from theMayo Clinic represented the ﬁrst ‘molecular
autopsy’ of RYR2 in cases of sudden unexplained death [72]. In the
cohort of 49 cases, six distinct RYR2missensemutations were found in
seven cases (14%). Next, Tester et al. [73] performed a study with the
aim to determine the spectrum and prevalence of RYR2mutations in a
cohort of 134 SIDS cases. Overall, two distinct and novel RYR2
mutations (p.R2267H and p.S4565R) were identiﬁed in two cases of
SIDS that were subsequently established to be mutation-negative for
all known LQTS susceptibility genes. Both amino acid substitutions
were absent in 400 reference alleles. Functional characterization
showed that the two mutant channels were prone to display a
signiﬁcant gain-of-function ‘leaky’ phenotype, especially under con-
ditions that simulate stress during diastole. These ﬁndings are
supported by the recent study by Mathur et al. [74], who created a
knock-in mouse model of SIDS and reported that youngmice with the
gain-of-function mutation p.R176Q in RYR2 [75] show an increased
propensity to calcium leak-induced cardiac arrhythmias and sudden
death. The nocturnal occurrence of cardiac arrhythmias in SIDS can be
explained by sudden increases in sympathetic activity, for example
following hypoxia or possibly even during REM sleep [73].4.4. Other cardiac ion channel-related mutations
The cardiac fast sodium channel is localized in caveolae, mem-
brane microdomains involved in vesicular trafﬁcking, whose major
component in cardiomyocytes is CAV3-encoded caveolin-3 [76]. Vatta
et al. [76] reported a novel type of the long QT syndrome (LQT9)
associated with mutations in CAV3 that result in a two- to threefold
increase in late sodium current compared with wild-type caveolin-3,
similar to the functional effect of LQT3-associated SCN5A mutations.
Cronk et al. [77] investigated the prevalence of LQT9 in 134 cases of
SIDS, and identiﬁed three distinct CAV3 mutations (p.V14L, p.T78M
and p.L79R). At functional characterization, all of these showed a
signiﬁcant ≈5-fold increase in late sodium current, consistent with
the LQT3-like phenotype described by Vatta et al. [76]. In their
population of 201 Norwegian SIDS cases, Arnestad et al. [43] also
identiﬁed two CAV3 variants (p.C72W and p.T78M). Since p.T78M had
earlier been characterized as a functionally signiﬁcant mutation [77],
this variant was considered pathogenic, although one of the two
victims with this variant also carried the functionally signiﬁcant
p.A586_L587del mutation in SCN5A. With regard to p.C72W, no
functional data are available. Of note, the p.C72W variant had actually
been designated as a common polymorphism in the original study
identifying CAV3 as the LQT9 locus [76].
London et al. [78] reported that the p.A280V mutation in the gene
GPD1-L, encoding the glycerol-3-phosphate dehydrogenase 1-like
protein (G3PD1L), reduced inward sodium current and thus caused
Brugada syndrome. Given this ﬁnding, Van Norstrand et al. [79] ana-
lyzed 83 cases of sudden unexplained death, including 7 SIDS cases,
and identiﬁed a GPD1-L mutation in a 3-month-old boy (p.E83K).
Further analysis of a cohort of 221 SIDS cases revealed two additional
mutations (p.I124V and p.R273C). All three mutations were absent in
600 reference alleles. Compared with wild-type, coexpression of
mutant GPD1-Lwith SCN5A resulted in a signiﬁcantly reduced sodium
current, consistent with a loss-of-function, BrS-like phenotype.
London et al. [78] found a reduced cell surface expression of SCN5A
with mutant GPD1-L and hypothesized that the mutation caused
impaired trafﬁcking of the cardiac sodium channel to the cell surface.
Valdivia et al. [80] later provided evidence that the effect of the
mutation in GPD1-L is through a reduced enzymatic function of
G3PD1L, which regulates SCN5A through direct phosphorylation,whereas another study [81] emphasizes the role of a mutation-
induced increase in the intracellular concentration of NADH.
In 2008, Ueda et al. [82] and Wu et al. [83] almost simultaneously
reported that mutations in SNTA1, encoding α1-syntrophin, may lead
to LQTS through a gain of function of the fast sodium channel, as in
LQT3. Ueda et al. [82] found that the p.A390V mutation led to LQTS
through increased direct S-nitrosylation of the cardiac sodium
channel, resulting in a marked increase in late sodium current. The
increase in late sodiumcurrentwas accompanied by an increase in peak
sodium current, an increase in sodium channel availability through a
+6mV shift in sodiumchannel inactivation, and a slower time course of
sodium current decay. Wu et al. [83] studied the p.A257G mutation in
SNTA1 and also found an increase in late sodium current, due to an
increase in peak sodium current, an increase in sodium channel
availability through a –9 mV shift in sodium channel activation, and a
slower time course of sodium current decay. Subsequently, Cheng et al.
[84] investigated the prevalence and functional properties of SNTA1
mutations in a cohort of 292 SIDS cases. Six mutations were found in
eight cases, with one particular mutation (p.P56S) identiﬁed in three
cases, and were absent in 800 reference alleles. In vitro, a signiﬁcant
increase in peak and late sodium current was observed for p.S287R,
p.T372M and p.G460S, which was reversed by a neuronal nitric
oxide synthase inhibitor. The other three variants (p.G54R, p.P56S
and p.T262P) showed functionally insigniﬁcant changes in the
sodium current.
Recently, Van Norstrand et al. [85] detected two novel missense
mutations (p.E42K and p.S272P) in GJA1, i.e. the gene that encodes the
gap junction channel protein connexin43 (Cx43), in their cohort of 292
SIDS cases. Functional studies were performed using dual whole cell
patch-clamp and revealed a strongly reduced gap junctional conduc-
tance for p.E42K compared to wild-type. Such strongly reduced
intercellular coupling may result in lethal ventricular arrhythmias, as
demonstrated in several conditional Cx43 knockout models [86].
5. Prevalence of cardiac ion channelopathies in SIDS
The data from the population-based cohort studies summarized in
Table 2 allow us to calculate the prevalence of cardiac ion channelo-
pathies among SIDS victims. In our calculations we ignore that a few
SIDS victims carried more than one ion channel-related mutation, as
described in Section 4, and thus appear in Table 2more than once. This
holds for the infant from the study by Tester and Ackerman [40] with
the KCNQ1-p.T600M and KCNH2-p.G294V variants, the infant from the
study by Millat et al. [48] with the KCNE1-p.T20I and SCN5A-p.S1333Y
mutations, and the infant from the study by Arnestad et al. [43] with
the CAV3-p.T78M and SCN5A-p.A586_L587del mutations. Further-
more, by merging data from different studies, we ignore differences in
the underlying populations, which are mostly from North American
origin, but also from African American [41], German [42], Norwegian
[43], French [48] and Japanese [46] origin.
First, we can calculate that 19.5% of the SIDS victims carried a
mutation in any of the 16 cardiac ion channel-related genes studied
and that there is evidence for malignancy of these mutations in the
majority of cases (13.5%). In a minority of cases (6.0%), as detailed in
Section 4, there are either no data on the functional effects of the
mutation or no functionally signiﬁcant effects have been observed, e.g.
in expression studies. In the latter case, there may still be latent
functional defects that are not evident under the conditions of the
functional test. For example, theremay be defects that only show their
malignancy in case of acidosis or in the context of a speciﬁc splice
variant, as for some of the SIDS associated SCN5A variants studied by
Wang et al. [60] (see Section 4.2). Another example is the SIDS
associated KCNQ1-p.K598R mutation, which seemed benign when
expressed in oocytes [46], but was later identiﬁed as an LQT1 causing
mutation in a clinical study [47] (see Section 4.1). Another factor that
may turn apparently benign mutations into malignant ones is high
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more severe with an increase in temperature, as demonstrated for
several sodium channel mutations associated with the Brugada
syndrome, e.g. in the studies by Dumaine et al. [87] and Keller et al.
[88], explaining fever-induced arrhythmias observed in BrS patients.
Recently, Amin et al. [89] demonstrated that fever is also a potential
trigger of life-threatening arrhythmias in the long QT syndrome.
Although direct evidence is lacking, arrhythmogenic events triggered
by high body temperature may also play a role in the etiology of SIDS.
So the prevalence of malignant cardiac ion channel-related
mutations among SIDS victims may actually be close to 20%. It may
even be higher, given that conventional genetic analysis may fail to
uncover severe mutations [90,91] and that the determination of
associations between SIDS andmutations in ion channel-related genes
is still an emerging ﬁeld, with several associations that have only
recently been reported [52,63,85] and others that remain to be tested,
e.g. a possible association between SIDS andmutations in the ankyrin-
B encoding gene ANK2, leading to the ankyrin-B syndrome and LQT4
[30]. Of note, the prevalence of LQTS and BrS associated mutations
among SIDS victims is much higher than the estimated prevalence of
1:2000 for both LQTS and BrS in the general population [29,30].
Second, we can conclude that mutations in INa channel related
genes are the most malignant ones. Mutations in the α subunit
encoding gene, SCN5A, are found in 5.2% of the SIDS victims (Table 2),
in accordance with the observation in adults that LQT3 has the most
severe clinical events [57] and that these events tend to occur during
sleep [92], as in SIDS. In total, more than half of the reported
mutations are related to the INa channel. In addition to the mutations
in SCN5A, there are mutations in the β subunit encoding genes SCN3B
and SCN4B (1.0%) and in ‘regulatory genes’ (CAV3, GPD1-L and SNTA1;
5.4%), adding up to a prevalence of 11.6% for mutations affecting INa,
with functional evidence available for 9.2% (Table 2). Similar
percentages for the ‘cardiac sodium Nav1.5 channelsome’ have
recently been reported by Van Norstrand et al. [93]. With a total
prevalence of 5.7%, with functional evidence in case of 2.7%, mutations
in potassium channel genes (KCNQ1, KCNE1, KCNH2, KCNE2, KCNJ2
and KCNJ8) seem less frequent and less malignant.
6. Concluding remarks
In this review,we show that a considerable number of SIDS victims,
although theymay have appeared healthy during their lives, do in fact
display genetic variants that are associated with clinical disorders.
Various mechanisms have been hypothesized or already proven to
play a role in the etiology of SIDS. In particular,mutations in cardiac ion
channel-related genes are of importance. Data from population-based
cohort studies suggest that cardiac ion channelopathies are present
in at least 20% of SIDS cases. Genetic analysis for these and other
mutations is therefore recommended in cases of sudden infant death.
However, more research is required to further elucidate the patho-
physiology of SIDS, and to determine whether genetic or electrocar-
diographic screening of apparently healthy infants should be pursued.
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